{"id":34493,"date":"2025-04-07T17:56:32","date_gmt":"2025-04-07T14:56:32","guid":{"rendered":"https:\/\/massivebio.com\/?p=34493"},"modified":"2025-05-26T12:51:45","modified_gmt":"2025-05-26T09:51:45","slug":"strategic-partnership-flatiron-health","status":"publish","type":"post","link":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/","title":{"rendered":"Massive Bio Announces Strategic Partnership with Flatiron Health to Enhance Patient Identification and Clinical Trial Enrollment"},"content":{"rendered":"<section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><em>April 2025<\/em><\/p>\n<p>Massive Bio, a global leader in leveraging artificial intelligence to streamline patient identification and recruitment for clinical trials, today announced a strategic partnership with Flatiron Health, a healthtech company integrating clinical research into everyday care. This collaboration aims to expand patient identification capabilities and improve clinical trial enrollment across the United States.<\/p>\n<p>The partnership brings together Massive Bio\u2019s AI-driven platform and robust U.S.-based patient database with Flatiron Health\u2019s research infrastructure and proprietary technology. By combining these strengths, both organizations will enhance access to personalized treatment options and accelerate clinical trial enrollment, particularly for patients who may not otherwise have access to these opportunities.<\/p>\n<p>\u201cFlatiron Health is excited to join forces with Massive Bio, combining expertise and resources to advance personalized treatment options for cancer patients,\u201d said Michael Bierl, Vice President, Clinical Research Partnerships and General Manager, Europe, Flatiron Health. \u201cBy leveraging Massive Bio\u2019s robust network and database, we can continue to utilize our cutting-edge tools to empower sites to progress research, enhance workflows and efficiencies, accelerate clinical trial pace, while ensuring diverse patient populations have access to life-changing treatments that might otherwise be out of reach.\u201d<\/p>\n<p>The collaboration will enable Massive Bio to identify patients on a per-study basis who are not currently enrolled in clinical trials but are geographically close to applicable participating sites. These patients will be referred to Flatiron\u2019s research network, where they can be onboarded and considered for potential enrollment using Flatiron\u2019s centralized patient identification services.<\/p>\n<p>\u201cAt Massive Bio, our mission is to make access to clinical trials truly patient-centric, ensuring the right patient is matched to the right trial at the right time\u2014no matter where they live,\u201d said Dr. Arturo Loaiza-Bonilla, Co-Founder and Chief Medical Officer at Massive Bio. \u201cBy pairing our AI-driven platform and concierge services with Flatiron Health\u2019s extensive research infrastructure, we can help physicians and care teams expedite trial enrollment, reduce disparities in access, and improve outcomes for more patients.\u201d<\/p>\n<p>\u201cWe are thrilled to collaborate with Flatiron Health to bring our advanced analytics and global network directly to the providers and patients who need them most,\u201d added Selin Kurnaz, PhD, Chief Executive Officer and Co-Founder of Massive Bio. \u201cThrough this partnership, we can streamline the identification process, accelerate enrollment timelines, and ultimately ensure that life-saving therapies reach the patients who stand to benefit the most\u2014faster and more efficiently than ever before.\u201d<\/p>\n<p>This strategic collaboration reflects a shared commitment between Massive Bio and Flatiron Health to support clinical trial innovation, modernize patient recruitment, and ensure equitable access to advanced cancer treatments.<\/p>\n<h2 style=\"font-size: 24px;\"><strong>About Massive Bio<\/strong><\/h2>\n<p>Massive Bio is a global leader in using artificial intelligence to streamline patient identification and recruitment for clinical trials. The company\u2019s innovative platform helps biopharma companies accelerate enrollment by leveraging a comprehensive database of patients across the U.S. and beyond. Massive Bio\u2019s technology-driven approach aims to improve trial efficiency and broaden access to clinical studies for patients worldwide.<\/p>\n<h2 style=\"font-size: 24px;\"><strong>About Flatiron Health<\/strong><\/h2>\n<p>Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, Flatiron Health continues to transform patients\u2019 real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.<\/p>\n<h2 style=\"font-size: 24px;\"><strong>Media Contacts<\/strong><\/h2>\n<h3 style=\"font-size: 18px;\"><strong>Massive Bio <\/strong><\/h3>\n<p>Mert Turkkan: <a href=\"mailto:mturkkan@massivebio.com\">mturkkan@massivebio.com<\/a><\/p>\n<h3 style=\"font-size: 18px;\"><strong>Flatiron Health <\/strong><\/h3>\n<p>Nina Toor: <a href=\"mailto:press@flatiron.com\">press@flatiron.com<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"April 2025 Massive Bio, a global leader in leveraging artificial intelligence to streamline patient identification and recruitment for clinical trials, today announced a strategic partnership with Flatiron Health, a healthtech company integrating clinical research into everyday care. This collaboration aims to expand patient identification capabilities and improve clinical trial enrollment across the United States. The...","protected":false},"author":11,"featured_media":34494,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-34493","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Massive Bio Announces Strategic Partnership with Flatiron Health<\/title>\n<meta name=\"description\" content=\"Massive Bio, a global leader in leveraging artificial intelligence to streamline patient identification and recruitment for clinical trials, today announced a strategic partnership with Flatiron Health, a healthtech company integrating clinical research into everyday care.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Massive Bio Announces Strategic Partnership with Flatiron Health to Enhance Patient Identification and Clinical Trial Enrollment %\" \/>\n<meta property=\"og:description\" content=\"Massive Bio, a global leader in leveraging artificial intelligence to streamline patient identification and recruitment for clinical trials, today announced a strategic partnership with Flatiron Health, a healthtech company integrating clinical research into everyday care.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-07T14:56:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-26T09:51:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/04\/Collaboration-Announcement-flatiron.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"767\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Massive Bio Announces Strategic Partnership with Flatiron Health","description":"Massive Bio, a global leader in leveraging artificial intelligence to streamline patient identification and recruitment for clinical trials, today announced a strategic partnership with Flatiron Health, a healthtech company integrating clinical research into everyday care.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/","og_locale":"en_US","og_type":"article","og_title":"Massive Bio Announces Strategic Partnership with Flatiron Health to Enhance Patient Identification and Clinical Trial Enrollment %","og_description":"Massive Bio, a global leader in leveraging artificial intelligence to streamline patient identification and recruitment for clinical trials, today announced a strategic partnership with Flatiron Health, a healthtech company integrating clinical research into everyday care.","og_url":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2025-04-07T14:56:32+00:00","article_modified_time":"2025-05-26T09:51:45+00:00","og_image":[{"width":1024,"height":767,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/04\/Collaboration-Announcement-flatiron.png","type":"image\/png"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"Massive Bio Announces Strategic Partnership with Flatiron Health to Enhance Patient Identification and Clinical Trial Enrollment","datePublished":"2025-04-07T14:56:32+00:00","dateModified":"2025-05-26T09:51:45+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/"},"wordCount":613,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/04\/Collaboration-Announcement-flatiron.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/","url":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/","name":"Massive Bio Announces Strategic Partnership with Flatiron Health","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/04\/Collaboration-Announcement-flatiron.png","datePublished":"2025-04-07T14:56:32+00:00","dateModified":"2025-05-26T09:51:45+00:00","description":"Massive Bio, a global leader in leveraging artificial intelligence to streamline patient identification and recruitment for clinical trials, today announced a strategic partnership with Flatiron Health, a healthtech company integrating clinical research into everyday care.","breadcrumb":{"@id":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/04\/Collaboration-Announcement-flatiron.png","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/04\/Collaboration-Announcement-flatiron.png","width":1024,"height":767,"caption":"Collaboration Announcement flatiron"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/strategic-partnership-flatiron-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/massivebio.com\/resources\/news-en\/"},{"@type":"ListItem","position":3,"name":"Massive Bio Announces Strategic Partnership with Flatiron Health to Enhance Patient Identification and Clinical Trial Enrollment"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists &amp; Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/34493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=34493"}],"version-history":[{"count":5,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/34493\/revisions"}],"predecessor-version":[{"id":35532,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/34493\/revisions\/35532"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/34494"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=34493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=34493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=34493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}